Apr 28, 2025
Greg Gregory, PhD | Executive VP, Partner
Cynthia Miller, MD, MPH, FACP | VP, Medical Director, Access Experience Team
Christopher Terrone | VP, Healthcare Insights, Market Access
Artificial intelligence (AI) is significantly transforming the healthcare sector, evolving from a tool used to streamline administrative tasks to one influencing essential clinical functions. For pharmaceutical manufacturers, understanding how their health system customers are using AI is crucial.
The adoption of AI can standardize care, modify drug utilization patterns, and ultimately shift market share. How Health Systems are Using AI in Clinical Decision-Making is a groundbreaking report that offers invaluable insights to help pharmaceutical companies understand and navigate this shift. The findings are derived from a survey of 25 decision-makers who are leading deployment of their health systems’ AI initiatives.
AI Governance Goes Mainstream
AI is no longer a fringe experiment in health systems. It's gaining structure and investment as organizations treat it like a core clinical and operational asset. AI governance is already established in 88% of health systems.
The report includes first-hand insights on:
The New Landscape of AI Governance and Expertise. A significant majority of surveyed health systems have established formal AI governing bodies, with significant representation from senior roles.
How Health Systems Are Deploying AI in Clinical Practice. AI is being used not only in diagnosis, but also in drug selection, and it is being deployed across a range of therapeutic areas.
The Data and Guidelines Informing Clinical AI. Clinical practice guidelines are the most influential source for shaping AI recommendations at health systems.
Expectations, Challenges, and Measuring Impact. Lack of clinician trust is a key barrier to AI integration, but not the only one.
How the Pharmaceutical Industry Can Collaborate and Contribute. A substantial majority of health systems are open to collaboration on AI initiatives. The report identifies the key pillars that will support these partnerships.
By understanding the trends and actions of health systems, pharmaceutical companies can shift their perspective from viewing AI as merely a tech trend to mapping it as an emerging factor driving patient care, medication access, and partnerships.
Want to see more examples, data, and strategies? Fill out the form below to access the complete report.
Download the Full Report